What is the two-invoice system of medicine

Question 1: The two-ticket system of the two-ticket system (pharmaceutical reform) What is the two-ticket system ? The Guangdong Provincial Health Department's forum said that next year's sunshine procurement of medicines will strictly implement the "two-invoice system". It is said that the two-invoice system will change the current problem of too many links in the circulation of medicines and price increases at various levels, and alleviate the pain of the public's expensive visits to the doctor. Outside the municipal area or remote areas can be allowed to "three votes", there are secondary dealers, but the distribution of the first-class distributor of the same manufacturer's varieties, in the same prefecture-level city can only be entrusted to 1-2 secondary dealers. For the implementation of the "two-ticket system", the representatives of hospitals and pharmaceutical companies are in favor. Chengdu Diao Pharmaceutical Group Co., Ltd. said Liu manager, the implementation of the "two-ticket system", can effectively reduce the circulation of drugs from the pharmaceutical company to the hospital, not only improves the efficiency, but also ensure the safety of medication, more conducive to the *** on the supervision of pharmaceuticals, in addition to preventing some unscrupulous dealers to use some of the fake drugs, substandard drugs for low-priced competition In addition, it can also prevent some unscrupulous dealers from utilizing some fake and inferior drugs to compete at low prices, and crack down on informal pharmaceutical companies. After the implementation of the "two-ticket system", it is inevitable that the original business structure and the choice of distribution companies to make great adjustments, but in the long run, the benefits are still very large. Dr. Lu of Xinghai Hospital said that the biggest beneficiary of the "two-invoice system" is still the patient, the intermediate links are reduced, the price of drugs will naturally come down. At the same time, the "two-ticket system" also guarantees the interests of the pharmaceutical companies, so some cheap old drugs can be placed in the hospital pharmacy. In the past, these cheap old drugs can not give seven votes, eight votes of the distributor to bring profits, so the pharmaceutical companies have to stop production of these drugs, or change into injections, and then the price doubled several times. Many dealers on the "two-ticket system" response is not consistent. Large dealers on the "two-ticket system" response is more optimistic, said Li, manager of Guangdong Kangmei Pharmaceuticals, "two-ticket system" can effectively improve the industry's industry concentration, improve competitiveness in response to the challenge of foreign businessmen, and at the same time to reduce the circulation link, so that the people get the real benefits. Benefits. The most worried should be those small and medium-sized distribution units. It is estimated that nearly 70% of the distributors in Guangdong will face the fate of being eliminated after the implementation of the "two-ticket system". In this regard, some medium-sized dealers began to expand venues and equipment, to improve their competitive strength, while some small dealers, has begun to start the industry. (Reporter Zhang Xiaolei, intern Zhang Yingyan, correspondent Chen Guangtai) Hong Kong - Guangzhou: life-saving drugs doubled in price? The same anti-cancer drug price difference of half, too many circulation links, "cif" is too high, Guangzhou patients can only look at the "drug" sigh Yesterday (22nd), Guangzhou citizen Mr. Li was found to be suffering from abdominal aortic aneurysm, the doctor recommended immediate surgery. However, nearly 130,000 yuan of imported coated stents far beyond his affordability. The same stent in Hong Kong sold for only 80,000 yuan! Yesterday (16th), the Guangdong Provincial Medical Institutions Drug Sunshine Purchasing Working Group released the "2008 Guangdong Provincial Medical Institutions Drug Sunshine Purchasing Implementation Program" on the Internet. The new program provides: by the impact of rising prices, allowing pharmaceutical companies to offer an increase this year. Experts analyze, compared with this year, in 2008, certainly most of the drugs will rise in price. In the price brush up a "rising sound", Guangdong people finally heard a good news: "difficult" drug prices really began to fall! From April to the beginning of this month, the province's hospitals around the drug has been fully enabled this year, "online price limit bidding sunshine procurement" of the new price. The vibration of the reform of the country, can really bring the people how much benefit? Yesterday, the Guangdong Provincial Health Department held a briefing to disclose the recent implementation of the province. "At present, the fixed-point production system of cheap drugs is still in the pilot stage, many aspects are still not perfect, but also need multi-sectoral coordination, the introduction of supporting policies to promote." National Development and Reform Commission drug pricing policy adviser, China Chemical and Pharmaceutical Industry Association senior engineer Yu Guanwen told reporters.

Question 2: Next year, the national implementation of the purchase and sale of drugs "two-ticket system" of the two-ticket system refers to what The two-ticket system simply means that the entire process of pharmaceutical sales can only open two invoices. Pharmaceutical companies from the pharmaceutical company to get the second invoice, selling drugs to the hospital to open the second invoice.

Question 3: How to explain the two-ticket system of pharmaceutical reform In January 2017, the State Council Healthcare Reform Office, together with the National Health and Family Planning Commission and other eight departments jointly issued a notice clearly, comprehensive healthcare reform pilot provinces (autonomous regions and municipalities) and public hospitals to take the lead in the implementation of the pilot city of the public healthcare institutions in the procurement of drugs "two-ticket system", encouraging other areas to implement the "two-ticket system", "two-ticket system". Encourage other areas to implement the "two-ticket system", in order to further reduce the inflated prices of drugs, reduce the burden of the masses of drugs.

"Two-ticket system" refers to the drugs sold from the pharmaceutical company to the first dealer to open an invoice, the dealer sold to the hospital to open another invoice to "two tickets" instead of the current common seven tickets, eight tickets to reduce the circulation of layers of exploitation, and each variety of The first-level distributor of each variety shall not exceed two. After the implementation of the "two-ticket system", it is inevitable that the original business structure and the selection of distribution enterprises to carry out a great deal of adjustment, but in the long run, the benefits are still very large. It is said that the two-invoice system will change the current problem of too many links in the circulation of drugs and the problem of price increases at various levels, so as to alleviate the pain of the public to see a doctor is expensive. How it will actually work remains to be seen, because three feet of ice is not a day's cold, and likewise three feet of ice is not a day's warmth. For reference.

Question 4: What is the impact of the two-ticket system of medicine on pharmaceutical marketing The two-ticket system will continue to push up the cost of running the business, aggravate the burden of corporate finance and taxation, and increase the difficulty and cost of financial processing. For the pharmaceutical industry, the industry's increased costs will eventually be transmitted to the price of drugs, pushing up the price of drugs. There have been two marketing models in China, one is the self-management model represented by foreign enterprises and some brand-name enterprises, and the other is the bottom-price investment model adopted by more and more enterprises. Self-operated mode has been high invoicing, and now the two-ticket system has little impact on it. For the bottom price investment model has a certain impact, enterprises to take the investment mode of operation costs are relatively lower, save space can be let to the patient, the price is more competitive. After the implementation of the two-ticket system, pushing up the operating costs of enterprises, the bottom price investment enterprise profit space is thin, and ultimately can only push back the sales price increase. Once implemented, some of the circulation business to over the ticket to make a living will disappear.

Question 5: What is the pharmaceutical industry double ticket system Tax tickets and pass with the goods (goods sales details)

Question 6: What is the difference between the one-ticket system and the two-ticket system? Enterprise purchasing and marketing activities, the settlement mode has a "one-ticket" settlement and "two-ticket" settlement of two

One-ticket settlement "is the implementation of the purchased goods to the factory price of one-ticket system, so that the top of the sale of goods uniformly open value-added tickets, including transportation costs. Transportation costs are included. "Two-ticket system settlement" is the seller of goods for the buyer to issue value-added tickets for its ex-factory price, the freight is separate from the transportation side of the freight invoices to the buyer

Question 7: The two-ticket system of medicine when the implementation of the implementation of the ah, has been implemented, but the effect is not good. Because the profit is enough, the phenomenon of overbilling can still not be avoided. Some time ago, FGW issued a document regulating the drug bluff factory prices, but do not know how the final strength. Although hospitals are now targeting four or five commercial companies, but commercial companies can take the drug bugs collected. Policy, countermeasures more than ah.

Question 8: high-value medical supplies will implement the two-ticket system? China's high-value supplies bidding since the release of the "Ningbo rules", step by step towards the abyss of price reductions. Sichuan, Zhejiang, Anhui, Hubei, Guangdong and other provinces issued by the procurement of consumables are also to suppress the price of consumables. The state is also promoting the "Ningbo rules", the core of which is also a price reduction. Although the various provinces of the bidding price of consumables was suppressed very low, but relatively speaking, there are also a little higher bid, and now volume purchasing, volume price linkage bargaining; the implementation of the "two ticket system", the implementation of the national price of consumables linkage, the provinces of consumables compared to take the lowest price as the national price of consumables, resulting in the consumables business is really bitter to say!

In the future, the future of the world's most important cities, the world's most important cities will be the same.

In terms of the future of the medical consumables industry, the market pattern of high-value consumables has changed, high-value consumables market is facing a reshuffle, small and medium-sized agents out of the game has become a reality, only the first-class agents in the province in order to survive, as a high-value consumables manufacturers to the market layout and pricing system and other factors to do to readjust.

The bidding of general consumables and test reagents is mainly based on the municipal bidding, which requires that medical device manufacturers who previously adopted the provincial model must channel down to form a market pattern centered on prefecture-level agents.

With many small and medium-sized agents out of the game will lead to small and medium-sized manufacturers of general supplies and test reagents are also eliminated out of the game, because each "municipal bidding" there will be thousands of general supplies and test reagents to do the enterprise bidding, two or three distributors can not possibly accommodate how much of the bidding of the medical supplies manufacturers, most of the small and medium-sized medical consumables manufacturer. Most of the small and medium-sized medical supplies manufacturers will also be eliminated from the game.

With the exit of small and medium-sized agents, the performance of large commercial companies, led by Sinopharm, will be explosive growth in the industry's influence, network construction, capital, strength will reach new heights. With the exit of small and medium-sized medical consumables manufacturers, the performance of well-known first-line brands of medical consumables also gained a substantial increase.

The new situation of medical consumables agents: eliminating a number of transformation of a number of As has become or want to become China's medical consumables well-known first-tier brands still rely on three aspects to achieve: technological innovation to drive the market, the optimal price-performance ratio advantage, and the integration of the power of capital.

Question 9: What is the difference between the two-vote system for drug procurement in public medical institutions The two-vote system looks to reduce the link in the question. But is not how to understand the drug is to save lives,